ロード中...
Analyses of publicly available genomics resources define FGF-2-expressing bladder carcinomas as EMT-prone, proliferative tumors with low mutation rates and high expression of CTLA-4, PD-1 and PD-L1
Fibroblast growth factor 2 (FGF-2) is overexpressed in a subset of invasive bladder carcinomas and its overexpression correlates with poor prognosis. Analyses of publicly available databases addressing the molecular mechanisms that may be responsible for the poor prognosis of these tumors, revealed...
保存先:
| 出版年: | Signal Transduct Target Ther |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5431749/ https://ncbi.nlm.nih.gov/pubmed/28515962 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sigtrans.2016.45 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|